Review Adherence to biologic therapies and associated factors in rheumatoid arthritis,
spondyloarthritis and psoriatic arthritis Page 1 559 1Complejo Hospitalario de Zamora, Zamora, …

Background Plasma concentrations of lipoprotein (a) (Lp(a)), a lipoprotein with atherogenic
and thrombogenic properties, have a strong genetic basis, although high concentrations of …

Purpose We assessed the efficacy and safety of biologic therapy in severe and refractory
Peripheral Ulcerative Keratitis (PUK). Design Open-label multicenter study of biologic-treated …

Objective To compare the prevalence of the main comorbidities in 2 large cohorts of patients
with primary Sjögren's syndrome (SS) and systemic lupus erythematosus (SLE), with a …

Objective: Since obesity has been associated with a higher inflammatory burden and worse
response to therapy in patients with chronic inflammatory rheumatic diseases (CIRD), we …

… Martín-Martínez, MD Santos Castañeda, MD, PhD Carlos González-Juanatey, MD, PhD
Fernando Sánchez-Alonso, MD Carmen García-Gómez, MD, PhD Ruth López-González …

Objective. Digestive involvement (DI) has been reported in 10–30% of primary Sjögren’s
syndrome (pSS) patients, and few studies have systematically analysed the prevalence of DI in …

OBJECTIVE: To analyze sociodemographic and clinic-associated factors of patients with
rheumatoid arthritis (RA) undergoing any orthopedic surgery (AOS) and total joint replacement (…

This study aimed at determining socio-demographic and clinical factors of primary Sjögren
syndrome (pSS) associated with osteoporosis (OP) and fragility fracture. SJOGRENSER is a …

Objective To analyze changes in the lag time to first disease modifying antirheumatic drug (DMARD)
prescription since onset of symptoms of rheumatoid arthritis (RA) over the last 2 …